Posted on 5/7/20
Former Celgene Shareholders' Contingent Value Rights Slip Further Away
On Wednesday, Bristol Myers Squibb (NYSE:BMY) told investors the FDA would require an extra three months to complete its review of liso-cel, a cell-based cancer therapy . . .
Posted on 5/7/20
CVS Health Beats Expectations in Q1 Due to COVID-19 Fears
CVS Health (NYSE:CVS) reported its first-quarter results before the market opened on Wednesday, announcing revenue up 8.3% year over year to $66.8 billion. That well exceeded . . .
Posted on 5/7/20
BERG Forms Research Collaboration With Boehringer Ingelheim
BERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, today announced a new collaboration with Boehringer Ingelheim around . . .
Posted on 5/7/20
AVROBIO and Magenta Therapeutics Announce Collaboration
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (Nasdaq: AVRO) and Magenta Therapeutics (Nasdaq: MGTA) today announced a research and clinical collaboration agreement to evaluate the potential utility of MGTA-117, . . .
Posted on 5/7/20
Kubtec Medical Imaging Partners with Surgeons
The COVID-19 pandemic is an unprecedented global health crisis, impacting all aspects of life and society. This includes breast cancer where patients' fears are now exacerbated . . .
Posted on 5/6/20
Polar Pak to Produce 2M Face Shields for Health Canada to Help Fight the COVID-19 Pandemic
A Novolex brand, Polar Pak will manufacture PPE face shields in Brampton, ONPolar Pak, a Canadian-based Novolex brand, announced it will be manufacturing more than 2 . . .
Posted on 5/6/20
Jounce Therapeutics Reports First Quarter 2020 Financial Results
CAMBRIDGE, Mass., May 06, 2020 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies . . .
Posted on 5/6/20
Constellation Pharmaceuticals Announces First-Quarter 2020 Financial Results
CAMBRIDGE, Mass., May 06, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, . . .
Posted on 5/6/20
Why Cognex Stock Soared 30% in April
What happenedShares in Cognex (NASDAQ:CGNX) rose by 30.8% in April, according to data provided by S&P Global Market Intelligence. The moves come down to the market . . .
Posted on 5/6/20
Here's How Warren Buffett Is Tackling the Retail Industry in 2020
Investing genius Warren Buffett took the podium for this weekend's Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) shareholder meeting to share his wisdom for three full hours. This company's . . .
Posted on 5/6/20
Lyra Therapeutics Closes IPO
WATERTOWN, Mass.--(BUSINESS WIRE)--Lyra Therapeutics, Inc. (Nasdaq: LYRA) today announced the closing of its initial public offering of 4,025,000 shares of common stock at a public offering . . .
Posted on 5/6/20
Pressure BioSciences Announces Planned Name Change to "Availa Bio"
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions . . .
Posted on 5/6/20
LaunchPad Medical Wins a $2.5M NIH Grant
LaunchPad Medical, Inc. announced that it has been awarded a $2.5 million Direct-to-Phase II Small Business Innovation Research (SBIR) grant (1R44NS115386) from the National Institute of . . .
Posted on 5/5/20
Harvard Bioscience Announces First Quarter 2020 Financial Results
HOLLISTON, Mass., May 05, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced financial results for the three months ended March 31, 2020.The Company . . .
Posted on 5/5/20
Putting Berkshire Hathaway's $50 Billion Loss In Context
SummaryWarren Buffett's Berkshire Hathaway reported a loss of nearly $50 billion in the first quarter of its 2020 fiscal year.The company was hit by a declining . . .
Posted on 5/5/20
Why Biogen Shares Fell 6.18% in April
What happenedBiogen (NASDAQ:BIIB) shares fell 6.18% in April, according to data provided by S&P Global Market Intelligence, as the biotech company said it would submit a . . .
Posted on 5/4/20
Applied BioMath Announces Collaboration with Zymeworks
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced the continuation of . . .
Posted on 5/4/20
Rhythm Pharmaceuticals Reports Q1 2020 Financial Results
BOSTON, May 04, 2020 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a late-stage biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare . . .
Posted on 5/4/20
Minerva Neurosciences Reports First Quarter 2020 Financial Results and Business Updates
WALTHAM, Mass., May 04, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central . . .
Posted on 5/3/20
Acer Therapeutics Announces Common Stock Purchase Agreement for up to $15M with Lincoln Park Capital
NEWTON, Mass., April 30, 2020 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for . . .
Posted on 5/3/20
Sarepta Therapeutics Announces Research Agreement with U.S. Department of Defense
CAMBRIDGE, Mass., April 28, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the Company . . .
Posted on 5/3/20
Biogen Prices $3.0 Billion of Senior Unsecured Notes
CAMBRIDGE, Mass., April 27, 2020 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB)announced today the pricing of two series of senior unsecured notes for an aggregate principal . . .
Posted on 5/3/20
Lyra Therapeutics Prices IPO
WATERTOWN, Mass.--(BUSINESS WIRE)--Lyra Therapeutics, Inc. (Nasdaq: LYRA) today announced the pricing of its initial public offering of 3,500,000 shares of common stock at a public offering . . .
Posted on 5/1/20
The Coronavirus Has Cost Buffett $1.1 Billion in Annual Dividend Income
Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) CEO Warren Buffett may well be the greatest investor of our time. We're talking about someone who first began investing in the stock . . .
Posted on 5/1/20
Syndax Prices Public Offering of Common Stock
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced today the pricing of an underwritten public offering of . . .

